Michael Cookson, MD,MHA

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Prokarium
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Pfizer
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Pacifice Edge Diagnostics
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    TesoRx Pharma LLC
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Bayer Healthcare Pharmaceuticals
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Myovant Sciences
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Astellas Pharma, Inc.
    Date added:
    Date updated:
    04/02/2024
Return to Update Series (2023) Lesson 12: Adjuvant and Early Salvage Therapy Recommendations Following Radical Surgery in Urologic Cancers